Aripiprazole, an Antipsychotic With a Novel Mechanism of Action, and Risperidone vs Placebo in Patients With Schizophrenia and Schizoaffective Disorder
Top Cited Papers
- 1 July 2003
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 60 (7), 681-690
- https://doi.org/10.1001/archpsyc.60.7.681
Abstract
Research from JAMA Psychiatry — Aripiprazole, an Antipsychotic With a Novel Mechanism of Action, and Risperidone vs Placebo in Patients With Schizophrenia and Schizoaffective DisorderKeywords
This publication has 1 reference indexed in Scilit:
- Compliance with antipsychotic drug treatment: influence of side effectsActa Psychiatrica Scandinavica, 1994